VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 5.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,226 | +209.6% | 283,804 | +429.2% | 0.01% | +100.0% |
| Q4 2022 | $396 | -100.0% | 53,627 | -58.7% | 0.01% | -57.1% |
| Q3 2022 | $1,282,000 | +102.5% | 129,785 | +123.4% | 0.01% | +100.0% |
| Q2 2022 | $633,000 | +65.3% | 58,093 | +137.6% | 0.01% | +250.0% |
| Q4 2021 | $383,000 | +1.6% | 24,450 | +39.1% | 0.00% | -33.3% |
| Q2 2021 | $377,000 | -16.8% | 17,571 | -41.9% | 0.00% | -40.0% |
| Q1 2021 | $453,000 | +319.4% | 30,226 | +168.0% | 0.01% | +66.7% |
| Q3 2020 | $108,000 | -66.6% | 11,279 | -60.1% | 0.00% | -70.0% |
| Q2 2020 | $323,000 | +29.7% | 28,282 | +86.4% | 0.01% | -9.1% |
| Q4 2019 | $249,000 | +88.6% | 15,174 | +44.8% | 0.01% | -82.3% |
| Q2 2015 | $132,000 | – | 10,477 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |